PPI-Regulating Short Peptide Drugs

Maximizing therapeutic effects with non-blood local injection
High specificity and pathology-specific fine regulation of target
Minimizing side effects by short half-life in blood

* PPI: Protein-Protein Interaction

Clinical Stage Pharmaceutical

Degenerative disc treatment drug P2K – US FDA Phase 3
Osteoarthritis treatment drug E1K – Korea MFDS Phase 2
TNBC anti-cancer drug C1K – Korea MFDS Phase 1

New Drugs For Medical Unmet Needs

New drugs treating diseases with no therapeutic alternatives;
Degenerative disc, Osteoarthritis, TNBC,
Alzheimer's disease, Type 1 diabetes, Atopic dermatitis

* TNBC: Triple Negative Breast Cancer